Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial.

MLA

Cardinale, Daniela, et al. “Prevention of Atrial Fibrillation in High-Risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial.” Annals of Surgery, vol. 264, no. 2, Aug. 2016, pp. 244–51. EBSCOhost, https://doi.org/10.1097/SLA.0000000000001626.

APA

Cardinale, D., Sandri, M. T., Colombo, A., Salvatici, M., Tedeschi, I., Bacchiani, G., Beggiato, M., Meroni, C. A., Civelli, M., Lamantia, G., Colombo, N., Veglia, F., Casiraghi, M., Spaggiari, L., Venturino, M., & Cipolla, C. M. (2016). Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial. Annals of Surgery, 264(2), 244–251. https://doi.org/10.1097/SLA.0000000000001626

Chicago

Cardinale, Daniela, Maria T Sandri, Alessandro Colombo, Michela Salvatici, Ines Tedeschi, Giulia Bacchiani, Marta Beggiato, et al. 2016. “Prevention of Atrial Fibrillation in High-Risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial.” Annals of Surgery 264 (2): 244–51. doi:10.1097/SLA.0000000000001626.